Cargando…
Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC
Aberrant methylation of CpG dinucleotides is a commonly observed epigenetic modification in human cancer. Thus, detection of aberrant gene promoter methylation as a tool for diagnosis of tumors or as a prognostic marker has been widely described for many types of cancers, including nonsmall cell lun...
Autores principales: | Xue, Ruilin, Yang, Cuili, Zhao, Fang, Li, Dejia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222896/ https://www.ncbi.nlm.nih.gov/pubmed/25382980 http://dx.doi.org/10.2147/OTT.S67355 |
Ejemplares similares
-
Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
por: Wu, Xiaoyu, et al.
Publicado: (2019) -
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017) -
Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells
por: Ghafoory, S, et al.
Publicado: (2015) -
Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer
por: Wang, Huan-qiang, et al.
Publicado: (2018) -
The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
por: Song, Xiao-yun, et al.
Publicado: (2016)